GOLDMAN SACHS GROUP INC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$388,313
+82.1%
132,530
+77.8%
0.00%
Q2 2023$213,210
+9.7%
74,549
+18.6%
0.00%
Q1 2023$194,309
+65.6%
62,883
+13.1%
0.00%
Q4 2022$117,303
-49.9%
55,594
-22.5%
0.00%
Q3 2022$234,000
+69.6%
71,758
+67.3%
0.00%
Q2 2022$138,000
-79.6%
42,903
-55.3%
0.00%
Q1 2022$678,000
+20.4%
95,966
+23.5%
0.00%
Q4 2021$563,00077,6850.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders